Progression and postoperative complications of osteoradionecrosis of the jaw: a 20-year retrospective study of 124 non-nasopharyngeal cancer cases and meta-analysis
- PMID: 35643546
- PMCID: PMC9148447
- DOI: 10.1186/s12903-022-02244-9
Progression and postoperative complications of osteoradionecrosis of the jaw: a 20-year retrospective study of 124 non-nasopharyngeal cancer cases and meta-analysis
Abstract
Background: To assess the contributing risk factors for the progression of, and the postoperative poor prognosis associated with, osteoradionecrosis of jaw (ORNJ) following non-nasopharyngeal cancer treatment in head and neck.
Methods: A retrospective study of 124 non-nasopharyngeal carcinoma patients in head and neck treated at one institution between 2001 and 2020 was conducted. A cumulative meta-analysis was conducted according to PRISMA protocol and the electronic search was performed on the following search engines: PubMed, Embase, and Web of Science. After assessing surgery with jaw lesions as a risk factor for the occurrence of ORNJ, 124 cases were categorized into two groups according to the "BS" classification, after which jaw lesions, chemotherapy, flap reconstruction and onset time of ORNJ were analyzed through the chi-square test and t-test to demonstrate the potential association between them and the progression of ORNJ. Postoperative outcomes of wound healing, occlusal disorders, and nerve injury were statistically analyzed.
Results: With the statistically significant results of the meta-analysis (odds ratio = 3.07, 95% CI: 1.84-5.13, p < 0.0001), the chi-square test and t-test were used to validate our hypotheses and identified that surgery with jaw lesions could aggravate the progression and accelerate the appearance of ORNJ. Patients who underwent chemotherapy tended to suffer from severe-to-advanced osteonecrosis but did not shorten the onset time of ORNJ. Flap reconstruction presented obvious advantages in wound healing (p < 0.001) and disordered occlusion (p < 0.005). The mean onset time of ORNJ in non-nasopharyngeal cancer patients (4.5 years) was less than that in patients with nasopharyngeal cancer (NPC) (6.8 years).
Conclusions: Iatrogenic jaw lesions are evaluated as a significant risk factor in the occurrence and progression of ORNJ in non-nasopharyngeal carcinoma patients who tend to have more severe and earlier osteonecrosis after radiotherapy than NPC patients. Flap reconstruction is a better choice for protecting the remaining bone tissue and reducing postoperative complications of ORNJ.
Keywords: Chemotherapy; Flap reconstruction; Head and neck cancer; Meta-analysis; Non-nasopharyngeal cancer; Osteoradionecrosis of the jaw; Postoperative complication.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.Radiat Oncol. 2021 Jan 5;16(1):1. doi: 10.1186/s13014-020-01701-5. Radiat Oncol. 2021. PMID: 33402192 Free PMC article.
-
Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients.J Stomatol Oral Maxillofac Surg. 2024 Jun;125(3S):101838. doi: 10.1016/j.jormas.2024.101838. Epub 2024 Mar 20. J Stomatol Oral Maxillofac Surg. 2024. PMID: 38518893
-
Fluorescence-guided surgery for osteoradionecrosis of the jaw: a retrospective study.J Int Med Res. 2022 Jun;50(6):3000605221104186. doi: 10.1177/03000605221104186. J Int Med Res. 2022. PMID: 35698727 Free PMC article.
-
Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.Morphologie. 2021 Jun;105(349):170-187. doi: 10.1016/j.morpho.2020.11.008. Epub 2020 Dec 3. Morphologie. 2021. PMID: 33281055 Review.
-
Pentoxifylline and tocopherol for the treatment of osteoradionecrosis of the jaws. A systematic review.Med Oral Patol Oral Cir Bucal. 2023 May 1;28(3):e293-e300. doi: 10.4317/medoral.25729. Med Oral Patol Oral Cir Bucal. 2023. PMID: 36641743 Free PMC article.
Cited by
-
Sarcomatoid carcinoma transformation in oral undifferentiated carcinoma following sequential immune combined targeted therapy: a case report.Front Immunol. 2024 Oct 24;15:1484915. doi: 10.3389/fimmu.2024.1484915. eCollection 2024. Front Immunol. 2024. PMID: 39512346 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical